|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.430 HKD | -5.45% |
|
-8.30% | -46.48% |
Company Valuation: Cutia Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,030 | 2,120 | 1,482 | 806.9 | - | - |
| Change | - | -30.05% | -30.06% | -45.57% | - | - |
| Enterprise Value (EV) 1 | 2,471 | 2,055 | 1,469 | 875.6 | 806.9 | 645.2 |
| Change | - | -16.83% | -28.53% | -40.38% | -7.85% | -20.04% |
| P/E | -1.04x | -4.72x | -3.96x | -4.85x | 17x | 2.14x |
| PBR | 2.25x | 2.17x | 1.52x | 1.75x | 1.59x | 1.15x |
| PEG | -0x | 0.1x | 0.1x | 0.1x | -0x | 0x |
| Capitalization / Revenue | 22x | 7.58x | 4.41x | 1.25x | 0.68x | 0.46x |
| EV / Revenue | 18x | 7.35x | 4.37x | 1.36x | 0.68x | 0.37x |
| EV / EBITDA | -4.96x | -4.89x | -5.69x | -7.37x | 9.89x | 1.45x |
| EV / EBIT | -4.58x | -4.46x | -4.89x | -6.11x | 15.3x | 2.64x |
| EV / FCF | -5.65x | -4.38x | -4.87x | -2.85x | -28.6x | 10.5x |
| FCF Yield | -17.7% | -22.8% | -20.5% | -35% | -3.5% | 9.55% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.6 | -1.41 | -1.03 | -0.4581 | 0.1304 | 1.038 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 137.6 | 279.6 | 336.2 | 645.9 | 1,180 | 1,738 |
| EBITDA 1 | -498 | -419.9 | -257.9 | -118.8 | 81.56 | 444.6 |
| EBIT 1 | -538.9 | -461.1 | -300.1 | -143.3 | 52.79 | 244.1 |
| Net income 1 | -1,964 | -433.8 | -340.2 | -145.7 | 44.25 | 330.6 |
| Net Debt 1 | -559.6 | -64.73 | -13.8 | 68.7 | - | -161.7 |
| Reference price 2 | 9.967 | 6.653 | 4.080 | 2.221 | 2.221 | 2.221 |
| Nbr of stocks (in thousands) | 304,024 | 318,588 | 363,368 | 363,368 | - | - |
| Announcement Date | 27/03/24 | 24/03/25 | 24/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.85x | 1.36x | -7.37x | - | 119M | |
| 34.75x | 12.42x | 25.87x | 0.58% | 1,043B | |
| 26.86x | 6.13x | 16.78x | 2.15% | 602B | |
| 33.14x | 7.52x | 15.43x | 2.7% | 449B | |
| 17.71x | 4.39x | 10.82x | 3.02% | 327B | |
| 21.31x | 5.47x | 13.24x | 2.89% | 279B | |
| 21.26x | 4.48x | 12.39x | 1.96% | 264B | |
| 24.37x | 6.42x | 11.35x | 2.71% | 201B | |
| -49.1x | 5.86x | 32.41x | 2.38% | 169B | |
| 12.77x | 3.12x | 7.88x | 6.86% | 143B | |
| Average | 13.82x | 5.72x | 13.88x | 2.81% | 347.72B | |
| Weighted average by Cap. | 23.88x | 7.73x | 18.23x | 2.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2487 Stock
- Valuation Cutia Therapeutics
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
